PULMATRIX, INC. Operating Lease, Liability, Current
PULMATRIX, INC. (PULM) had Operating Lease, Liability, Current of $24.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-13.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2025-03-21
- 2024-06-30: Operating Lease, Liability, Current $24.00K.
- 2024-03-31: Operating Lease, Liability, Current $383.00K.
- 2023-12-31: Operating Lease, Liability, Current $429.00K.
- 2023-09-30: Operating Lease, Liability, Current $199.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2024-06-30 | $24.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $383.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $429.00K 10-K · filed 2025-03-21 |
| 2023-09-30 | $199.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $358.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $779.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $857.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $1.28M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.70M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $1.57M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.43M 10-K · filed 2023-03-30 |
| 2021-09-30 | $898.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.18M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $1.16M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $1.14M 10-K · filed 2022-03-29 |
| 2020-09-30 | $997.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $861.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $511.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $675.00K 10-K · filed 2021-03-23 |
| 2019-01-01 | $1.28M 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |